-
Mashup Score: 41
Objectives. This study was performed to the efficacy, safety and clinical consequences of abrupt cessation of quinapril therapy in a placebo-controlle…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage. “This single-center experience demonstrates use of pulmonary MRA as a practical substitute for…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ARRS_Radiology Preferential use of pulmonary #MR #angiography (#MRA) for diagnosing #pulmonaryembolus (PE) in the general population helped conserve #iodinated #contrastmedia during the 2022 shortage: https://t.co/yFwUwg3fUb
-
-
Mashup Score: 0
June 29, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), preferential use of pulmonary MR angiography(MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage. “This single-center experience demonstrates use of pulmonary MRA as a practical substitute for…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ARRS_Radiology New report says preferential use of #pulmonary MR #angiography (#MRA) for diagnosing #pulmonaryembolus (PE) in the general population helped conserve #iodinated #contrastmedia during the 2022 shortage: https://t.co/Mlo8LHJkYz
-
-
Mashup Score: 9Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure - 12 month(s) ago
This Viewpoint advocates for expanded use of quadruple therapy in patients with heart failure with reduced ejection fraction.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
🔥#HeartFailureAwarenessDays #HFAD LastDay D7 1day = 1theme 🍀 The good news is that #HF is treatable 🚀 Fast starting & titration of #ARNI #BB #MRA #SGLT2i significantly ⬇️ morbidity & ☠️ 🏰 #SGLT2i pillar for #HFpEF @gcfmd @DrRajivsankar @iamritu https://t.co/wYEGYUufKW https://t.co/geBax8Qrof
-
-
Mashup Score: 2Non-steroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease - 1 year(s) ago
ABSTRACT. The burden of adverse cardiorenal outcomes among patients with the trifecta of diabetes, heart failure (HF) and chronic kidney disease (CKD) remains h
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Happening Now 📢 @ERAkidney #JournalClub! Incoming @BrighamFellows @KevinBryanLo sharing his @NDTsocial paper Nonsteroidal #MRA & Cardiorenal Outcomes MR takes center stage over next several yrs in #HF #CKD #rHTN @willkidney @P_Rossing @RangaswJ 📎 https://t.co/ch4OvU4Zv9 https://t.co/h4BwGYDTJD
-
-
Mashup Score: 8
Beart failure with reduced ejection fraction (HFrEF) is a leading cause of morbidity and mortality. However, shortfalls in prescribing of proven thera…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
4th wrap-up from #ACC2023 significant impact on clinical practice: ❤️🔥 #BETTER_CARE_HF 🔥 An Electronic Health Record with a digital alert significantly ⬆️ #MRA prescription in #HFrEF @AndrewJSauer @gcfmd @JJheart_doc @RFE_Pedretti @hvanspall @iamritu https://t.co/YNFAowk5HO https://t.co/cGq2p4egVG
-
-
Mashup Score: 12
Abstract. As heart failure (HF) enters a new era with high level of evidence supporting the use of individual drug therapies, we put forth a rationale for the n
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
The last decade established building blocks of #CaReMe. The next will drive implementation & test different drugs in combo. T2D: #SGLT2i + #GLP1RA HF & CKD: #SGLT2i + #MRA Obesity: #GLP1 + #GIP + #Glucagon Super⭐️@vbluml discusses in @escardio #EHJSuppl https://t.co/MiPfvDExIR https://t.co/hlwGQsxAuA
-
-
Mashup Score: 1Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study | NEJM - 1 year(s) ago
Original Article from The New England Journal of Medicine — Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
Sadly, #MRA appears lowest in 🇺🇸 & 🇨🇦, falling below global standards. These countries ranked *last* in background #MRAs in recent RCTs like #DELIVER (actually highest in 🇷🇺 as in #STRONGHF) ? long-term legacy of Ontario post-#RALES hyperK+ safety signal https://t.co/u63l4cuxU3 https://t.co/QeM5IYMgc4
-
-
Mashup Score: 0Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population - 2 year(s) ago
Introduction Mineralocorticoid receptor antagonists (MRAs) reduce mortality and morbidity in patients with heart failure and reduced ejection fraction (HFrEF), but are largely underused. We evaluated the frequency, motives, predictors and outcomes of MRA discontinuation in a real-world heart failure population. Methods and results This was a single-centre, retrospective cohort study where…
Source: Open HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Motives, frequency, predictors & outcomes of #MRA discontinuation in a real-world HF population https://t.co/tPBKZAdUsc https://t.co/awoxVQN6Me
-
-
Mashup Score: 11Mineralocorticoid Receptor Antagonists and SGLT2 Inhibitor Therapy: The Best of Both Worlds in HFrEF ∗ - 2 year(s) ago
Corresponding Author
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
@AndrewJSauer Mineralocorticoid Receptor Antagonists and #SGLT2i Therapy: The Best of Both Worlds in HFrEF #SGLT2i ❤️ #MRA https://t.co/Ykw7xpXRLg https://t.co/vWLBdpCMGO
-
Withdrawal of #GDMT in HF consistently ➡️adverse clinical course⚠️ #ACEi in HFrEF (#QuinaprilHeartStudy) https://t.co/9AsSNhBxAv #SGLT2i in HF (#EMPEROR) https://t.co/Z6FPyhABjs #MRA in HFmrEF/HFpEF (tested in #FINEARTS) #GDMT in HFimpEF DCM (#TREDHF) https://t.co/oKGUIWqjXB https://t.co/JJz252EpAL https://t.co/39HPhyZHjw